Director, Product Management, Oncology, Molecular Residual Disease (MRD)

Responsibilities

• Lead portfolio strategy and lifecycle management, including roadmap development, forecasting, and performance optimization from concept through commercialization and scale.
• Apply deep disease expertise, regulatory insight, and business acumen to drive adoption, profitability, and sustained portfolio growth.
• Monitor scientific, regulatory, and competitive trends to inform strategic direction and investment priorities.
• Develop robust business cases encompassing market opportunity, segmentation, financial projections, operating models, and product requirements.
• Serve as the commercial lead across R&D, Operations, and Market Access, ensuring alignment on product strategy, pricing, and go-to-market approach.
• Represent the voice of the customer in governance and planning forums, incorporating insights into prioritization and product evolution.
• Drive strategic partnerships that enhance product capabilities, expand access, and create new revenue opportunities.
• Partner with Product and Customer Marketing to support differentiation, positioning, and thought leadership.
• Ensure operational readiness for launches, enhancements, and acquisitions, including workflow design and execution.
• Analyze utilization, access, and performance metrics to continuously improve product outcomes and inform leadership decisions.
• Collaborate with Commercial, Medical Affairs, and Scientific teams on field enablement, evidence generation, and customer engagement.

Requirements

• Bachelor’s degree in Molecular Biology, Life Sciences or Bioengineering.
• 7 or more years experience in product management or portfolio strategy.
• 7 or more years experience in diagnostics, pharmaceuticals, or life sciences.
• 5 or more years managing diagnostic services or oncology testing products.

Preferred Qualifications

• 3 or more years experience in circulating tumor DNA (ctDNA), NGS, or oncology diagnostics.
• 2 or more years experience with MRD, liquid biopsy, or longitudinal testing.
• Advanced degree in Molecular Biology, Oncology or Life Sciences.

Skills And Competencies

• Strategic thinking
• Product lifecycle management & commercialization
• Scientific and clinical fluency
• Analytics and forecasting capability
• Stakeholder influence
• Operational and financial acumen
• Competitive insight
• Strong product strategy and lifecycle management capability
• Deep understanding of oncology clinical workflows and treatment paradigms
• Technical fluency in ctDNA, NGS technologies, and assay performance tradeoffs
• Knowledge of U.S. diagnostic reimbursement and access pathways
• Strong analytical, financial modeling, and storytelling skills
• Proven ability to lead cross functional teams without direct authority
• Comfort engaging external oncologists, pathologists, and scientific leaders
• Ability to operate in areas of clinical and regulatory uncertainty

About The Role

As a global leader in diagnostic services, Labcorp is committed to improving health and improving lives. Diagnostic Marketing plays a central role as a commercial partner, driving access to innovative testing solutions, strengthening leadership in specialized diagnostics, advancing digital capabilities, and enhancing customer experience to support sustainable growth. Within this function, the Director of Product Management is responsible for portfolio strategy, commercialization, and lifecycle execution to ensure strong product performance and successful launches. The role aligns cross-functional stakeholders and represents the commercial perspective across R&D, Operations, and Market Access. It also leads forecasting, resource planning, and operational efficiency, translating market insights into strategic decisions that expand margins, improve competitiveness, and drive profitable growth. The Director, Oncology (MRD) leads the strategy and lifecycle management of Labcorp’s molecular residual disease (MRD) portfolio. This includes advancing differentiated solutions that enable treatment monitoring, early detection of recurrence, and ongoing cancer management across solid tumors and hematologic malignancies. This role translates evolving clinical evidence, emerging technologies (including tumor-informed and tumor-naive approaches), payer dynamics, and competitive trends into actionable strategies that drive adoption and access. Working cross-functionally with Science, Medical Affairs, Product Marketing, Commercial Strategy, Market Access, IT, and Operations, the Director ensures seamless, best-in-class customer experience from test ordering through reporting. The position also requires close collaboration with oncologists, pathologists, translational researchers, and MRD thought leaders, as well as engagement with biopharma partners to support therapy-specific applications and clinical trial integration.